State Of Wyoming Athenex, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $0.91 $5,058 - $11,228	-12,339 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.79 - $1.59 $8,146 - $16,396	10,312 Added 508.73%	12,339 $10,000
Q4 2021 Feb 11, 2022	BUY	$1.36 - $2.94 $46 - $99	34 Added 1.71%	2,027 $3,000
Q3 2021 Feb 11, 2022	BUY	$2.97 - $4.84 $3,382 - $5,512	1,139 Added 133.37%	1,993 $6,000
Q2 2021 Feb 11, 2022	BUY	$3.71 - $5.13 $3,168 - $4,381	854 New	854 $4,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.